Published on:

Excedrin Migraine Hits the Black Market

As a longtime sufferer of headaches, I know how great it is to find something that honestly works to quickly take away the pain. Would I pay $2.45 for a pill for to take away the pain, when a few weeks ago that same pill was $.02 per pill? That, I’m not quite sure. It sounds crazy, but that is exactly what seems to be happening.

In January of this year, Excedrin Migraine, amongst a few other over-the-counter medications, was recalled. The drugmaker Novartis recalled these items after issues at its production facility in Nebraska lent themselves to contamination. As a result, Excedrin Migraine was pulled from the shelves. When will it return, nobody knows, but Novartis says this:

We are working hard to return products to store shelves as soon as possible. Novartis Consumer Health will restart production on a line-by-line, product-by-product basis to ensure control and adherence to our high standard of quality and expects to begin shipments of a limited portfolio of products in the second half of the year. We are currently in the very early stages of validating our manufacturing processes.

In the meantime, headache suffers are left to suffer the pain, or shell out the big bucks. Is it worth it? Only a true headache suffer can tell you.